newsfilter
← Latest News
PR Newswire·

Provention Bio to Report First Quarter 2022 Financial Results on May 5, 2022

RED BANK, N.J., April 28, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its first quarter 2022 financial results